Jupiter Neurosciences, Inc. Common Stock (NASDAQ:JUNS) — Market Cap & Net Worth
Market Cap & Net Worth: Jupiter Neurosciences, Inc. Common Stock (JUNS)
Jupiter Neurosciences, Inc. Common Stock (NASDAQ:JUNS) has a market capitalization of $3.27 Million ($3.27 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29307 globally and #5913 in its home market, demonstrating a -41.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jupiter Neurosciences, Inc. Common Stock's stock price $0.09 by its total outstanding shares 36281252 (36.28 Million). Review Jupiter Neurosciences, Inc. Common Stock (JUNS) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
Jupiter Neurosciences, Inc. Common Stock Market Cap History: 2024 to 2026
Jupiter Neurosciences, Inc. Common Stock's market capitalization history from 2024 to 2026. Data shows change from $388.21 Million to $3.27 Million (-93.31% CAGR).
Index Memberships
Jupiter Neurosciences, Inc. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #862 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2731 of 3165 |
Weight: Jupiter Neurosciences, Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Jupiter Neurosciences, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jupiter Neurosciences, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1697.87x
Jupiter Neurosciences, Inc. Common Stock's market cap is 1697.87 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $37.01 Million | $21.80K | -$8.64 Million | 1697.87x | N/A |
Competitor Companies of JUNS by Market Capitalization
Companies near Jupiter Neurosciences, Inc. Common Stock in the global market cap rankings as of August 3, 2026.
Key companies related to Jupiter Neurosciences, Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
Jupiter Neurosciences, Inc. Common Stock Historical Marketcap From 2024 to 2026
Between 2024 and today, Jupiter Neurosciences, Inc. Common Stock's market cap moved from $388.21 Million to $ 3.27 Million, with a yearly change of -93.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.27 Million | -91.18% |
| 2025 | $37.01 Million | -90.47% |
| 2024 | $388.21 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Jupiter Neurosciences, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.27 Million USD |
| MoneyControl | $3.27 Million USD |
| MarketWatch | $3.27 Million USD |
| marketcap.company | $3.27 Million USD |
| Reuters | $3.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jupiter Neurosciences, Inc. Common Stock
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinic… Read more